heart disease
Quest Diagnostics, Zora Biosciences Sign Licensing Agreement for Cardiovascular Biomarkers
The company signed a non-exclusive license for Zora's ceramide markers and plans to launch a test based on the markers as early as next year.
Proxim Diagnostics Developing Handheld Analyzer for Point-of-Care, SARS-CoV-2 Testing
The firm is developing a test to determine interleukin-6 levels for SARS-CoV-2 patients and a rapid antigen test.
Wyss Institute Developing Multiplex Electrochemical Testing Platform for Multiple Disease Conditions
The iQ Group Global is integrating the Wyss Institute's technology with its own organic thin-film biosensor platform for SARS-CoV-2 serology testing.Â
AACC, CDC to Expand Lipid Testing Globally
The partnership will provide new point-of-care lipid testing devices to remote sites in Latin America, the Caribbean, and Asia-Pacific.
MIP Diagnostics Developing SARS-CoV-2, Troponin Molecularly Imprinted Polymers
The firm said that it has begun developing its own products using synthetic affinity reagent technology acquired five years ago from the University of Leicester.
Jan 28, 2020
Oct 2, 2019
Aug 14, 2019
Salveo Dx Merges With ImmunArray, Nudge
Jun 4, 2019
Nov 15, 2018
Oct 31, 2018
Diagnostics Firm 1Drop Raises $4.25M
Oct 8, 2018
Sphingotec Closes €20M in Equity Financing
Sep 27, 2018